Technical Analysis for SBIO - ALPS Medical Breakthroughs ETF
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Historical SBIO trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Up 4 Days in a Row | Strength | 0.00% | |
| Up 5 Days in a Row | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| Crossed Above 200 DMA | Bullish | 0.30% | |
| Upper Bollinger Band Walk | Strength | 0.30% | |
| Outside Day | Range Expansion | 0.30% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | 3 days ago |
| Rose Above Previous Day's High | 3 days ago |
| Fell Below Upper Bollinger Band | 3 days ago |
| Rose Above Previous Day's High | 4 days ago |
| Outside Day | 4 days ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM.
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.
Keywords: Exchange Traded Fund ETF Index Fund Biotechnology Pharmaceutical Passive Management
Classification
Keywords: Exchange Traded Fund ETF Index Fund Biotechnology Pharmaceutical Passive Management
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 64.04 |
| 52 Week Low | 37.2 |
| Average Volume | 25,345 |
| 200-Day Moving Average | 49.05 |
| 50-Day Moving Average | 47.54 |
| 20-Day Moving Average | 46.81 |
| 10-Day Moving Average | 47.64 |
| Average True Range | 1.14 |
| ADX | 20.58 |
| +DI | 33.00 |
| -DI | 21.47 |
| Chandelier Exit (Long, 3 ATRs) | 46.54 |
| Chandelier Exit (Short, 3 ATRs) | 46.75 |
| Upper Bollinger Bands | 49.54 |
| Lower Bollinger Band | 44.09 |
| Percent B (%b) | 1.05 |
| BandWidth | 11.65 |
| MACD Line | 0.45 |
| MACD Signal Line | -0.09 |
| MACD Histogram | 0.5405 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 50.77 | ||||
| Resistance 3 (R3) | 50.71 | 50.34 | 50.61 | ||
| Resistance 2 (R2) | 50.34 | 50.09 | 50.36 | 50.55 | |
| Resistance 1 (R1) | 50.07 | 49.94 | 49.89 | 50.13 | 50.50 |
| Pivot Point | 49.70 | 49.70 | 49.60 | 49.73 | 49.70 |
| Support 1 (S1) | 49.43 | 49.45 | 49.25 | 49.49 | 49.12 |
| Support 2 (S2) | 49.06 | 49.30 | 49.09 | 49.07 | |
| Support 3 (S3) | 48.80 | 49.06 | 49.01 | ||
| Support 4 (S4) | 48.85 |
